Business
CSL (ASX:CSL) share price heads lower on haemophilia B deal
The CSL Limited (ASX: CSL) share price is slightly lower today despite announcing plans to buy rights for novel late-stage gene therapy candidate.
In late afternoon trade, the global biotech’s shares are swapping hands for $276.06, down 0.5%.
What did CSL announce?
Investors appear…
Continue Reading
-
Noosa News21 hours agoFervor Wines label started during pandemic keeps father and son close
-
Business23 hours agoThese ASX 200 shares could rise 15% to 20%
-
Business22 hours agoEvery ASX 200 sector closed in the red last week. Here’s why
-
Business24 hours agoBuy NDQ ETF and these popular funds with $5,000